Literature DB >> 16648516

A call for clinical trials: lipophilic statins may prove effective in treatment and prevention of particular breast cancer subtypes.

Anjali S Kumar, Michael Campbell, Christopher C Benz, Laura J Esserman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16648516     DOI： 10.1200/JCO.2005.04.9882

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  13 in total

1.  Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin.

Authors:  Thomas P Ahern; Per Damkier; Søren Feddersen; Anders Kjærsgaard; Timothy L Lash; Stephen Hamilton-Dutoit; Cathrine Bredal Lythjohan; Bent Ejlertsen; Peer M Christiansen; Deirdre P Cronin-Fenton
Journal:  Acta Oncol       Date:  2020-04-30       Impact factor: 4.089

2.  Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors.

Authors:  Marilyn L Kwan; Laurel A Habel; E Dawn Flick; Charles P Quesenberry; Bette Caan
Journal:  Breast Cancer Res Treat       Date:  2007-08-03       Impact factor: 4.872

3.  Statin prescriptions and breast cancer recurrence risk: a Danish nationwide prospective cohort study.

Authors:  Thomas P Ahern; Lars Pedersen; Maja Tarp; Deirdre P Cronin-Fenton; Jens Peter Garne; Rebecca A Silliman; Henrik Toft Sørensen; Timothy L Lash
Journal:  J Natl Cancer Inst       Date:  2011-08-02       Impact factor: 13.506

4.  An analysis of the association between statin use and risk of endometrial and ovarian cancers in the Women's Health Initiative.

Authors:  Pinkal Desai; Robert Wallace; Matthew L Anderson; Barbara V Howard; Roberta M Ray; Chunyuan Wu; Monika Safford; Lisa W Martin; Thomas Rohan; JoAnn E Manson; Michael S Simon
Journal:  Gynecol Oncol       Date:  2018-02-13       Impact factor: 5.482

5.  Statin use and breast cancer risk in a large population-based setting.

Authors:  Denise M Boudreau; Onchee Yu; Diana L Miglioretti; Diana S M Buist; Susan R Heckbert; Janet R Daling
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

Review 6.  Statins and breast cancer prognosis: evidence and opportunities.

Authors:  Thomas P Ahern; Timothy L Lash; Per Damkier; Peer M Christiansen; Deirdre P Cronin-Fenton
Journal:  Lancet Oncol       Date:  2014-09       Impact factor: 41.316

7.  The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study.

Authors:  Cathryn H Bock; Allison M Jay; Gregory Dyson; Jennifer L Beebe-Dimmer; Michele L Cote; Lifang Hou; Barbara V Howard; Pinkal Desai; Kristen Purrington; Ross Prentice; Michael S Simon
Journal:  Breast Cancer Res Treat       Date:  2017-10-24       Impact factor: 4.872

Review 8.  Chemoprevention of hormone receptor-negative breast cancer: new approaches needed.

Authors:  Iván P Uray; Powel H Brown
Journal:  Recent Results Cancer Res       Date:  2011

Review 9.  Prevention of ER-negative breast cancer.

Authors:  Yuxin Li; Powel H Brown
Journal:  Recent Results Cancer Res       Date:  2009

Review 10.  Statins: do they have a potential role in cancer prevention and modifying cancer-related outcomes?

Authors:  Stefanos Bonovas
Journal:  Drugs       Date:  2014-10       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.